Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
Anaesthesia, surgery, and challenges in postoperative recovery
2003 Standout
A network biology approach to prostate cancer
2007
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression
2017
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial
2002 Standout
Perioperative management of patients with alcohol, tobacco and drug dependency
2010
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Short-term preoperative smoking cessation and postoperative complications: a systematic review and meta-analysis
2011
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Late Adrenal Metastasis in Operable Non–Small-Cell Lung Carcinoma
2002
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Origin and prognostic value of circulating KRAS mutations in lung cancer patients
2007
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
Lung Cancer
2008 Standout
Glioblastoma and Other Malignant Gliomas
2013 Standout
Resistance mechanisms to cancer chemotherapy
2008
Smoking Cessation Reduces Postoperative Complications: A Systematic Review and Meta-analysis
2011
Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer
2008 Standout
Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas
2005
Multimodal strategies to improve surgical outcome
2002 Standout
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2004
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
2002 Standout
Network medicine: a network-based approach to human disease
2010 Standout
Hypermethylation of the Death-Associated Protein (DAP) Kinase Promoter and Aggressiveness in Stage I Non-Small-Cell Lung Cancer
2000
RAS Is Regulated by the let-7 MicroRNA Family
2005 Standout
Prognostic impact of histologic demonstration of Chromogranin A and Neuron Specific Enolase in pulmonary adenocarcinoma
1991
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
2010
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Malignant Gliomas in Adults
2008 Standout
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Blocking Oncogenic Ras Signaling for Cancer Therapy
2001
Functional evaluation before lung resection
2002
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Clinical development of platinum complexes in cancer therapy: an historical perspective and an update
1998
Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life
2010
Gastric cancer
2020 Standout
MicroRNA signatures in human cancers
2006 Standout
Primary brain tumours in adults
2012 Standout
Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung
2001
Gene-expression profiles predict survival of patients with lung adenocarcinoma
2002 Standout
MUC1 and the MUCs: A Family of Human Mucins with Impact in Cancer Biology
2004
The structural biochemistry of the superoxide dismutases
2009
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
2012 Standout
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Inhibition of touch cell fate by egl-44 and egl-46 in C. elegans
2001 StandoutNobel
Silicosis
2012 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Consensus guidelines for enhanced recovery after gastrectomy
2014
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Quality Indicators for Colonoscopy
2014
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
2002 Standout
Copper Active Sites in Biology
2014 Standout
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Preoperative evaluation of the lung cancer resection candidate
2010
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Interventions for preoperative smoking cessation
2014
KRASMutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer
2007
Anticoagulation: Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings
2009
Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.
2000
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Quality Indicators for Colonoscopy
2006
Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib
2005
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
2001 Standout
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Quality indicators for colonoscopy
2014 Standout
Chemically tunable mucin chimeras assembled on living cells
2015 StandoutNobel
Guidelines for Perioperative Care in Elective Colonic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Pneumoconiosis from Agricultural Dust Exposure among Young California Farmworkers
2009
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma
2008
IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines
1994
Simple Sugars to Complex Disease—Mucin-Type O-Glycans in Cancer
2015
Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED]
2000
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
2010
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Works of Nancy Newman being referenced
Prognostic Significance of Lewis y Antigen in Resected Stage I and II Non-small Cell Lung Cancer
1998
Prognostic Markers in Resected Non–Small-Cell Lung Cancer: An Patients with 5 Year Follow-Up
1999
Anticonvulsant usage is associated with an increased risk of procarbazine hypersensitivity reactions in patients with brain tumors
1997
Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer
2005
Phase I — Preliminary phase II trial of iproplatin, a cisplatin analogue
1988
The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.
1989
Preoperative Smoking Habits and Postoperative Pulmonary Complications
1998
Phase II Study of Iproplatin (CHIP) in Previously Treated Small-Cell Lung Cancer
1989
The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer
2002
Phase II Trial of Iproplatin (CHIP) in Previously Untreated Patients with Colorectal Cancer
1988
Postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel therapy
2010
Low‐Molecular‐Weight Heparin May Alter Point‐of‐Care Assay for International Normalized Ratio
2005
A Phase II Trial of Iproplatin (CHIP) in Previously Treated Advanced Breast Cancer
1989
MnSOD genotype and prostate cancer risk as a function of NAT genotype and smoking status.
2009
Inorganic Dust Exposure Causes Pulmonary Fibrosis in Smokers: Analysis Using Light Microscopy, Scanning Electron Microscopy, and Energy Dispersive X-Ray Spectroscopy
2006
Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung Cancer
1999
Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.
1997